Evidence map›Paper›PMID 33471826›Full record

ArticlePloS one2021

Cluster analysis of resistance combinations in Escherichia coli from different human and animal populations in Germany 2014-2017.

Beneditta Suwono, Tim Eckmanns, Heike Kaspar, Roswitha Merle, Benedikt Zacher, Chris Kollas, Armin A Weiser, Ines Noll, Marcel Feig, Bernd-Alois Tenhagen

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Clinical epidemiology and case fatality due to antimicrobial resistance in Germany: a systematic review and meta-analysis, 1 January 2010 to 31 December 2021.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2023
    Pooled it
  2. Article
  3. Article
  4. Antimicrobial Susceptibility Profiles ofAntibiotics (Basel, Switzerland) · 2025
    Article
  5. Antimicrobial Susceptibility Profiles of CommensalAntibiotics (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Beneditta SuwonoDepartment Biological Safety, Unit Epidemiology, Zoonoses and Antimicrobial Resistance, German Federal Institute for Risk Assessment, Berlin, Germany.ORCID 0000-0001-5021-6510
Tim EckmannsDepartment Infectious Disease Epidemiology, Unit Healthcare-associated Infections, Surveillance for Antibiotic Resistance and Consumption, Robert Koch Institute, Berlin, Germany.
Heike KasparUnit Antibiotic Resistance Monitoring, Federal Office of Consumer Protection and Food Safety, Berlin, Germany.
Roswitha MerleDepartment of Veterinary Medicine, Institute for Veterinary Epidemiology and Biostatistics, Working Group Applied Epidemiology, Free University Berlin, Berlin, Germany.ORCID 0000-0002-8688-2926
Benedikt ZacherDepartment Infectious Disease Epidemiology, Unit Healthcare-associated Infections, Surveillance for Antibiotic Resistance and Consumption, Robert Koch Institute, Berlin, Germany.
Chris KollasDepartment Biological Safety, Unit Epidemiology, Zoonoses and Antimicrobial Resistance, German Federal Institute for Risk Assessment, Berlin, Germany.
Armin A WeiserDepartment Biological Safety, Unit Epidemiology, Zoonoses and Antimicrobial Resistance, German Federal Institute for Risk Assessment, Berlin, Germany.
Ines NollDepartment Infectious Disease Epidemiology, Unit Healthcare-associated Infections, Surveillance for Antibiotic Resistance and Consumption, Robert Koch Institute, Berlin, Germany.
Marcel FeigDepartment Infectious Disease Epidemiology, Unit Healthcare-associated Infections, Surveillance for Antibiotic Resistance and Consumption, Robert Koch Institute, Berlin, Germany.
Bernd-Alois TenhagenDepartment Biological Safety, Unit Epidemiology, Zoonoses and Antimicrobial Resistance, German Federal Institute for Risk Assessment, Berlin, Germany.
Robert Koch Institute · DEFederal Institute for Risk Assessment · DEFederal Office of Consumer Protection and Food Safety · DEFreie Universität Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent findings on Antibiotic Resistance (AR) have brought renewed attention to the comparison of data on AR from human and animal sectors. This is however a major challenge since the data is not harmonized. This study performs a comparative analysis of data on resistance combinations in Escherichia coli (E. coli) from different routine surveillance and monitoring systems for human and different animal populations in Germany. Data on E. coli isolates were collected between 2014 and 2017 from human clinical isolates, non-clinical animal isolates from food-producing animals and food, and clinical animal isolates from food-producing and companion animals from national routine surveillance and monitoring for AR in Germany. Sixteen possible resistance combinations to four antibiotics-ampicillin, cefotaxime, ciprofloxacin and gentamicin-for these populations were used for hierarchical clustering (Euclidian and average distance). All analyses were performed with the software R 3.5.1 (Rstudio 1.1.442). Data of 333,496 E. coli isolates and forty-one different human and animal populations were included in the cluster analysis. Three main clusters were detected. Within these three clusters, all human populations (intensive care unit (ICU), general ward and outpatient care) showed similar relative frequencies of the resistance combinations and clustered together. They demonstrated similarities with clinical isolates from different animal populations and most isolates from pigs from both non-clinical and clinical isolates. Isolates from healthy poultry demonstrated similarities in relative frequencies of resistance combinations and clustered together. However, they clustered separately from the human isolates. All isolates from different animal populations with low relative frequencies of resistance combinations clustered together. They also clustered separately from the human populations. Cluster analysis has been able to demonstrate the linkage among human isolates and isolates from various animal populations based on the resistance combinations. Further analyses based on these findings might support a better one-health approach for AR in Germany.

Indexed as

Drug Resistance, BacterialAnimalsAnti-Bacterial AgentsCefotaximeCiprofloxacinCluster AnalysisEscherichia coliEscherichia coli InfectionsGermanyHumansMicrobial Sensitivity TestsPoultrySwineAnti-Bacterial AgentsCefotaximeCiprofloxacin

Identifiers

PMID33471826
PMCPMC7817003
OpenAlexW3116495150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.